Screener
Boston Scientific BSX EBITDA
EBITDA at other companies
Other financials
Where this comes from
Calculated from Boston Scientific’s reported figures.
The source filing: Boston Scientific’s 10-Q, filed May 1, 2026. Open the filing →
- Filed
- May 1, 2026, 6:25 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000885725-26-000033
FAQ
- What is Boston Scientific's EBITDA?
- Boston Scientific (BSX) reported EBITDA of $1.45B in Q1 2026.
- How has Boston Scientific's EBITDA changed year-over-year?
- Boston Scientific's EBITDA increased by 16.5% year-over-year, from $1.25B to $1.45B.
- What is the long-term trend for Boston Scientific's EBITDA?
- Over 4 years (2021 to 2025), Boston Scientific's EBITDA has grown at a 21.4% compound annual growth rate (CAGR), from $2.29B to $4.98B.
- What does EBITDA mean?
- Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.
Ask your AI about Boston Scientific's ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude